BRAF analysis of the melanoma tissue sample
stage IIB to IV primary melanoma
tests per year, UK, at presentation, for stage IIB to IV (considered for stage IIA, not for IA or IB)
“Carry out BRAF analysis of melanoma tissue samples from people with stage IIB to IV primary melanoma.”
NICE NG14, Melanoma: assessment and management, recommendation 1.3.10, 2022-07
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- A tumour mutation test (often immunohistochemistry for BRAF V600E first, recommendation 1.3.12) that decides targeted therapy. Recommendation dated 2022.
Used in
Kept as evidence; no figure on the platform is computed from it yet.